The SNP at the 15q15.1 risk location can boost the anti-apoptotic activity of BCL2 by mediating the mutation of the proapoptotic gene BMF and the TF RELA recruitment to a SE in CLL [35]. Here, BMF is linked to B-cell chronic lymphocytic leukemia.